Century Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Century Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Century Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $389M, a 2.25% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$389M	-$8.93M	-2.25%	Sep 30, 2024	10-Q	2024-11-05
Q2 2024	$416M	-$713K	-0.17%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$349M	-$108M	-23.6%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$361M	-$126M	-25.9%	Dec 31, 2023	10-Q	2024-11-05
Q3 2023	$398M	-$114M	-22.3%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$417M	-$115M	-21.7%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$456M	-$94.1M	-17.1%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$487M	+$49.2M	+11.2%	Dec 31, 2022	10-K	2024-03-14
Q3 2022	$512M	+$42M	+8.95%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$533M	+$37M	+7.46%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$550M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$437M	+$331M	+310%	Dec 31, 2021	10-K	2023-03-16
Q3 2021	$470M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$496M			Jun 30, 2021	10-Q	2021-08-12
Q4 2020	$107M			Dec 31, 2020	10-K	2022-03-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.